Stephens raised the firm’s price target on Pacs Group to $40 from $37 and keeps an Overweight rating on the shares. Pacs Group continues to execute on its opportunity to harvest $80M-$100M of EBITDA in 2024-2025 from acquired facilities, driving a 15% EBITDA beat in Q2 and subsequent 2024 guidance raise by 5% at the midpoint vs. the prior outlook, the analyst tells investors in a research note. The firm sees Pacs displaying a beat and raise tempo throughout 2024 given year-to-date performance and historical earnings seasonality showcasing a stronger second half performance relative to first half.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACS:
